Carmofur

153.85 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]；158.89 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]；157.91 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]；148.42 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]；H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

L - Antineoplastic and immunomodulating agents；L01 - Antineoplastic agents；L01B - Antimetabolites；L01BC - Pyrimidine analogues；L01BC04 - Carmofur

QL - Antineoplastic and immunomodulating agents；QL01 - Antineoplastic agents；QL01B - Antimetabolites；QL01BC - Pyrimidine analogues；QL01BC04 - Carmofur